REDUCED LDL-APOPROTEINS AND INCREASED HDL-APOPROTEINS IN PATIENTS WITH HYPERCHOLESTEROLEMIA UNDER TREATMENT WITH BEZAFIBRATE

被引：34

作者：

MORDASINI, R ^{[1
]}

RIESEN, W ^{[1
]}

OSTER, P ^{[1
]}

KELLER, M ^{[1
]}

MIDDELHOFF, G ^{[1
]}

LANG, PD ^{[1
]}

机构：

[1] UNIV BERN,TIEFENAU HOSP,INST CLIN PROT RES,CH-3004 BERN,SWITZERLAND

来源：

ATHEROSCLEROSIS | 1981年 / 40卷 / 02期

关键词：

D O I：

10.1016/0021-9150(81)90033-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：153 / 158

页数：6

共 14 条

[1]

ARNTZ HR, 1978, MED KLIN, V73, P1731

[2] HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].

CASTELLI, WP ;

DOYLE, JT ;

GORDON, T ;

HAMES, CG ;

HJORTLAND, MC ;

HULLEY, SB ;

KAGAN, A ;

ZUKEL, WJ .

CIRCULATION, 1977, 55 (05) :767-772

[3] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINATION OF BEZAFIBRATE IN SERUM AND URINE [J].

ENDELE, R .

JOURNAL OF CHROMATOGRAPHY, 1978, 154 (02) :261-263

[4] HIGH-DENSITY LIPOPROTEIN AS A PROTECTIVE FACTOR AGAINST CORONARY HEART-DISEASE - FRAMINGHAM STUDY [J].

GORDON, T ;

CASTELLI, WP ;

HJORTLAND, MC ;

KANNEL, WB ;

DAWBER, TR .

AMERICAN JOURNAL OF MEDICINE, 1977, 62 (05) :707-714

[5]

GUNDERSEN K, 1976, ATHEROSCLEROSIS, V25, P303, DOI 10.1016/0021-9150(76)90035-6

[6]

KAFFARNIK H, 1978, INT C ATHEROSCLEROSI, P129

[7] DRUG-TREATMENT OF PRIMARY HYPERLIPOPROTEINEMIA [J].

KLOSE, G ;

MORDASINI, R ;

MIDDELHOFF, G ;

AUGUSTIN, J ;

GRETEN, H .

KLINISCHE WOCHENSCHRIFT, 1978, 56 (03) :99-110

[8]

KLOSE G, 1979, LIPOPROTEINE HERZINF, P185

[9]

MILLER GJ, 1975, LANCET, V1, P16

[10] DOSE-RESPONSE STUDY OF BEZAFIBRATE ON SERUM LIPOPROTEIN CONCENTRATIONS IN HYPERLIPOPROTEINEMIA [J].

OLSSON, AG ;

LANG, PD .

ATHEROSCLEROSIS, 1978, 31 (04) :421-428

← 1 2 →